Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

DAG analogues as potent PKC agonists available for licensing

Oct. 25, 1996

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

NIH offers peptides with OMT residues as potential therapeutic agents

Oct. 25, 1996

Novel APC-based method for producing cancer therapeutics and vaccines available for licensing

Oct. 25, 1996

Human chorionic gonadotropin use in Kaposi's sarcoma described: NIH seeks licensees

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Oct. 25, 1996

Enzon selects Medac as marketing partner for Oncaspar

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...